Publicaciones

Compartir en redes sociales

1. When left does not seem right: epigenetic and bioelectric differences between left- and right-sided breast cancer.Masuelli Sofía, Real Sebastián, Campoy Emanuel, María Teresita Branham, Diego Matías Marzese, Salomon Matthew, Gerardo De Blas, Arias Rodolfo, Levin Michael, Roqué María. Mol Med 2022. doi: 10.1186/s10020-022-00440-5.

2. CDC42 as an epigenetic regulator of ID4 in triple-negative breast tumors. Daniela Nasif, Sebastián Real, María Roqué, María T Branham. Breast Cancer 2022. doi: 10.1007/s12282-022-01334-4.

3. Clinical and molecular characterization of mitochondrial DNA disorders in a group of Argentinian pediatric patients. Loos MA, Gomez G, Mayorga L, Horacio R, Taratuto AL, Saccoliti M, Alonso CN, and Araoz HV. MGM reports. 2021;27. Doi: 10.1016/j.ymgmr.2021.100733

4. A modelling study highlights the power of detecting and isolating asymptomatic or very mildly affected individuals for COVID-19 epidemic management. Mayorga L, García Samartino C, Flores G, Masuelli S, Sánchez MV, Mayorga LS and Sánchez CG. BMC Public Health 20, 1809 (2020).

5. Maternally inherited Leigh syndrome detected by Multiplex ligation-dependent probe amplification. Mayorga L, Cueto JA, Correa AP, Guillamondegui MJ, Loos MA, Araoz VH, and Roqué M. Mitochondrial DNA Part B 2019;4:530–3. doi:10.1080/23802359.2018.1553510.

6. Working together for the family: HER oncogenes co-amplifications in breast cancer. Sergio Laurito, María T. Branham, Emanuel M. Campoy, Sebastián Real, Juan Cueto, Guillermo Urrutia, Francisco Gago, Olga Tello, Telma Glatstein, Paola De la Iglesia, Lilit Atanesyan, Suvi Savola and María Roqué. Oncotarget, 2020

7. Intratumor heterogeneity index of breast carcinomas based on DNA methylation profiles. Emanuel M. Campoy, María T. Branham, Luis S. Mayorga and María Roqué. BMC Cancer, 2019

8. Mitochondrial stress triggers a pro-survival response through epigenetic modifications of nuclear DNA. Lía Mayorga, Betiana N. Salassa, Diego M. Marzese, Mariana A. Loos, Hernán D. Eiroa, Fabiana Lubieniecki, Clara García Samartino,Patricia S. Romano,María Roqué. Cellular and Molecular Life Sciences, 2019

9. PAX6 promoter methylation correlates with MDA-MB-231 cell migration, MMP2 and MMP9 expression. Urrutia G, Laurito S, Campoy E, Nasif D, Branham T and Roqué M. Asian Pacific Journal of Cancer Prevention 2018.

10. Epigenetic regulation of ID4 in breast cancer: tumor suppressor or oncogene? Nasif D, Campoy E, Laurito S. Branham R, Urrutia G, Roqué M and Branham T. Clinical Epigenetics 2018 10:111

11. TP73 DNA methylation and upregulation of ΔNp73 are associated with an adverse prognosis in breast cancer. Gomez LC, Sottile ML, Guerrero-Gimenez ME, Zoppino FCM, Redondo AL, Gago FE, Orozco JI, Tello OM, Roqué M, Nadin SB, Marzese DM, Vargas-Roig LM. Journal of Clinical Pathology. 2018 Jan;71(1):52-58. doi: 10.1136/jclinpath-2017-204499.

12. A frame-shift deletion in the PURA gene associates with a new clinical finding: Hypoglycorrhachia. Is GLUT1 a new PURA target? Mayorga L, Gamboni B, Mampel A y Roqué M. Molecular Genetics and Metabolism 2018 Mar;123(3):331-336).

13. Análisis de Variaciones del Número de Copias y de Patrones de Metilación en la Región 15q11-q13. Laurito SR y Roqué M. Medicina (B Aires) 2017 2018;78(1):1-5

14. Asymmetric Cancer Hallmarks in Breast Tumors on Different Sides of the Body. Campoy EM, Laurito SR, Branham MT, Urrutia G, Mathison A, Gago F, Orozco J, Urrutia R, Mayorga LS, Roqué M. PLos One. 2016

15. Epigenetic Regulation of ID4 in the Determination of the BRCAness Phenotype in Breast Cancer. Branham MT, Campoy E, Laurito S, Urrutia G, Gago F, Orozco J, Urrutia R and Roqué. M. Breast Cancer Research and Treatment. Jan;155(1):13-23. 2016.